A Cohort Study of Conversion From Aranesp® to NESP® for the Treatment of Anemia in Dialysis Patients

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

November 30, 2017

Study Completion Date

November 30, 2017

Conditions

AnemiaEnd Stage Renal Failure on Dialysis

Interventions

OTHER

Darbepoetin alfa

Conversion from Aranesp® to NESP®

Trial Locations (1)

Division of Nephrology, Department of Medicine, Queen Mary Hospital, Hong Kong

All Listed Sponsors

lead

The University of Hong Kong

OTHER

NCT02439697 - A Cohort Study of Conversion From Aranesp® to NESP® for the Treatment of Anemia in Dialysis Patients | Biotech Hunter | Biotech Hunter